Xenon Pharmaceuticals Inc (XENE) — Cash Flow Quality Index
Xenon Pharmaceuticals Inc (XENE) has a Cash Flow Quality Index of -2.41x as of December 2014. Operating cash flow of $-2.95 Million is below net income of $1.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of Xenon Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xenon Pharmaceuticals Inc Cash Flow Quality Index (2013–2014)
Historical Cash Flow Quality Index for Xenon Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check XENE tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Xenon Pharmaceuticals Inc (2013–2014)
Year-by-year earnings quality comparison for Xenon Pharmaceuticals Inc. For live market cap and the full company financial profile, see Xenon Pharmaceuticals Inc (XENE) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 0.02x | $266.00K | $13.02 Million | ▲ +107.4% |
| 2013 | -0.28x | $-3.32 Million | $12.03 Million | — |